A Rollover Study to Provide Continued Treatment With Eltrombopag
Clinical trial NCT01957176 · COMPLETED
Trial details
- NCT number
- NCT01957176
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-15
- Primary completion
- 2022-02-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.